40AM 40mg*10vials

5-Amino-1MQ 40AM 40mg*10vials

5-Amino-1MQ is a novel small molecule research compound designed to inhibit NNMT (Nicotinamide N-methyltransferase), an enzyme that consumes NAD+ and regulates cellular metabolism. It represents an ultra-high-concentration research compound in metabolic and longevity studies.

The 40mg single-vial specification delivers eight times the active ingredient content of the standard 5mg. This flagship formulation is engineered for ultra-long-term large animal models, extreme high-dose NAD+ pathway validation, and large-scale multi-group parallel research projects. The exceptionally high concentration per vial eliminates repeated dilution steps across extended experimental timelines, reducing data deviation and operational errors from frequent solution preparation.

Through its NNMT inhibitory action, 5-Amino-1MQ supports comprehensive research into cellular NAD+ level maintenance, fat metabolism regulation, and energy production. It is designed to study how blocking NNMT can preserve NAD+ availability, supporting metabolic health, fat reduction, and cellular energy balance.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Each batch undergoes comprehensive purity testing, with a full certificate of analysis provided.

10 vials per pack, designed for top-tier professional research institutions and large-scale global procurement.